| scholarly article | Q13442814 |
| P50 | author | Gary Van Domselaar | Q87490335 |
| P2093 | author name string | Aaron Farnsworth | |
| Anwar M Hashem | |||
| Xuguang Li | |||
| Carole L Yauk | |||
| Changgui Li | |||
| Jun Gao | |||
| Wangxue Chen | |||
| Jingxin Cao | |||
| Jessie R Lavoie | |||
| Michael Rosu-Myles | |||
| Terry Cyr | |||
| Marsha S Russell | |||
| Abenaya Muralidharan | |||
| Louise Larocque | |||
| Marybeth Creskey | |||
| P2860 | cites work | Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia--RSV recombinants or RSV. | Q52443988 |
| Induction and Subversion of Human Protective Immunity: Contrasting Influenza and Respiratory Syncytial Virus. | Q52649839 | ||
| Cotton rat model for testing vaccines and antivirals against respiratory syncytial virus. | Q54209804 | ||
| Protective Role of Nuclear Factor Erythroid 2-Related Factor 2 Against Respiratory Syncytial Virus and Human Metapneumovirus Infections. | Q54217591 | ||
| The CD8 T Cell Response to Respiratory Virus Infections. | Q55101403 | ||
| Elevated Fibrinogen Levels Are Associated with Risk of Pulmonary Embolism, but Not with Deep Venous Thrombosis | Q58007565 | ||
| Regulation of murine protein C gene expression in vivo: effects of tumor necrosis factor-alpha, interleukin-1, and transforming growth factor-beta | Q73141010 | ||
| Interleukin-1 (IL-1) immunohistochemistry assay in oral squamous cell carcinoma | Q88037662 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease | Q26775152 | ||
| MyD88: a central player in innate immune signaling | Q28087307 | ||
| Diversifying animal models: the use of hispid cotton rats (Sigmodon hispidus) in infectious diseases | Q28210290 | ||
| Influenza-induced tachypnea is prevented in immune cotton rats, but cannot be treated with an anti-inflammatory steroid or a neuraminidase inhibitor | Q28258658 | ||
| Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis | Q29619821 | ||
| Activation of coagulation and tissue fibrin deposition in experimental influenza in ferrets | Q30363101 | ||
| Platelet activation induced by human antibodies to interleukin-8. | Q33344855 | ||
| The role of nuclear factor-kappa B in pulmonary diseases | Q33916843 | ||
| Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine | Q34206177 | ||
| New insights for development of a safe and protective RSV vaccine | Q34249859 | ||
| Nucleoprotein nanostructures combined with adjuvants adapted to the neonatal immune context: a candidate mucosal RSV vaccine. | Q34289051 | ||
| Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease | Q34330690 | ||
| Regulation of mast-cell and basophil function and survival by IgE. | Q34931931 | ||
| RSV vaccine-enhanced disease is orchestrated by the combined actions of distinct CD4 T cell subsets | Q35174945 | ||
| Host proteome correlates of vaccine-mediated enhanced disease in a mouse model of respiratory syncytial virus infection | Q35488618 | ||
| Human metapneumovirus induces more severe disease and stronger innate immune response in BALB/c mice as compared with respiratory syncytial virus | Q35629152 | ||
| IL-17A produced by αβ T cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contraction | Q35874754 | ||
| Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus | Q36858777 | ||
| Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV | Q37002523 | ||
| The effects of interleukin-8 on airway smooth muscle contraction in cystic fibrosis | Q37078405 | ||
| Mechanisms of immunity to respiratory syncytial virus in cotton rats | Q37103582 | ||
| Formalin-inactivated respiratory syncytial virus vaccine induces antibodies to the fusion glycoprotein that are deficient in fusion-inhibiting activity. | Q37153108 | ||
| Protective CD8 T cell-mediated immunity against influenza A virus infection following influenza virus-like particle vaccination | Q37184801 | ||
| Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection | Q37212728 | ||
| Infection and inflammation as risk factors for thrombosis and atherosclerosis | Q37991556 | ||
| The emerging role of neutrophils in thrombosis-the journey of TF through NETs | Q38069578 | ||
| New fundamentals in hemostasis | Q38072904 | ||
| The changing landscape of respiratory syncytial virus | Q38561753 | ||
| Advances in RSV vaccine research and development - A global agenda | Q38815042 | ||
| Immunopathogenesis associated with formaldehyde-inactivated RSV vaccine in preclinical and clinical studies | Q39007664 | ||
| Transient Depletion of CD169+ Cells Contributes to Impaired Early Protection and Effector CD8+ T Cell Recruitment against Mucosal Respiratory Syncytial Virus Infection | Q40104785 | ||
| Immunization with Low Doses of Recombinant Postfusion or Prefusion Respiratory Syncytial Virus F Primes for Vaccine-Enhanced Disease in the Cotton Rat Model Independently of the Presence of a Th1-Biasing (GLA-SE) or Th2-Biasing (Alum) Adjuvant | Q40349822 | ||
| Combined orcein and martius scarlet blue (OMSB) staining for qualitative and quantitative analyses of atherosclerotic plaques in brachiocephalic arteries in apoE/LDLR-/- mice | Q40441817 | ||
| An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine | Q40940832 | ||
| Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35 expressing the respiratory syncytial virus (RSV) fusion protein induce protective immunity against RSV infection in cotton rats | Q41026321 | ||
| Transcriptional induction of multiple cytokines by human respiratory syncytial virus requires activation of NF-kappa B and is inhibited by sodium salicylate and aspirin | Q41105440 | ||
| An insect cell derived respiratory syncytial virus (RSV) F nanoparticle vaccine induces antigenic site II antibodies and protects against RSV challenge in cotton rats by active and passive immunization | Q41721418 | ||
| Palivizumab is highly effective in suppressing respiratory syncytial virus in an immunosuppressed animal model | Q43407951 | ||
| Cytokine and chemokine gene expression after primary and secondary respiratory syncytial virus infection in cotton rats | Q44677974 | ||
| Virus-specific IgE enhances airway responsiveness on reinfection with respiratory syncytial virus in newborn mice | Q45201335 | ||
| The TLR4 agonist, monophosphoryl lipid A, attenuates the cytokine storm associated with respiratory syncytial virus vaccine-enhanced disease. | Q45417025 | ||
| Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine | Q45734744 | ||
| Local interferon-gamma levels during respiratory syncytial virus lower respiratory tract infection are associated with disease severity | Q45736571 | ||
| Both immunisation with a formalin-inactivated respiratory syncytial virus (RSV) vaccine and a mock antigen vaccine induce severe lung pathology and a Th2 cytokine profile in RSV-challenged mice | Q45739409 | ||
| Pulmonary lesions in primary respiratory syncytial virus infection, reinfection, and vaccine-enhanced disease in the cotton rat (Sigmodon hispidus). | Q45746077 | ||
| Effectiveness of RSVIG prophylaxis and therapy of respiratory syncytial virus in an immunosuppressed animal model | Q45748021 | ||
| The use and misuse of Penh in animal models of lung disease | Q47939778 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cytokine | Q212354 |
| respiratory disease | Q3286546 | ||
| P304 | page(s) | 597 | |
| P577 | publication date | 2019-01-01 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Unveiling Integrated Functional Pathways Leading to Enhanced Respiratory Disease Associated With Inactivated Respiratory Syncytial Viral Vaccine | |
| P478 | volume | 10 |
Search more.